A detailed history of Burns Matteson Capital Management, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Burns Matteson Capital Management, LLC holds 1,738 shares of NVO stock, worth $186,313. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,738
Previous 2,082 16.52%
Holding current value
$186,313
Previous $297 Million 30.37%
% of portfolio
0.12%
Previous 0.19%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$119.07 - $145.42 $40,960 - $50,024
-344 Reduced 16.52%
1,738 $207 Million
Q2 2024

Jul 08, 2024

BUY
$122.71 - $146.91 $13,252 - $15,866
108 Added 5.47%
2,082 $297 Million
Q1 2024

May 13, 2024

SELL
$102.11 - $135.92 $408 - $543
-4 Reduced 0.2%
1,974 $253 Million
Q4 2023

Jan 12, 2024

BUY
$87.78 - $105.45 $173,628 - $208,580
1,978 New
1,978 $205 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $242B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Burns Matteson Capital Management, LLC Portfolio

Follow Burns Matteson Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Burns Matteson Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Burns Matteson Capital Management, LLC with notifications on news.